DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
The cellular prion protein does not affect tau seeding and spreading of sarkosyl-insoluble fractions from Alzheimer’s disease
The cellular prion protein (PrP) plays many roles in the developing and adult brain. In addition, PrP binds to several amyloids in oligomeric and prefibrillar forms and may act as a putative receptor of abnormal misfolded protein species. The role of PrP in tau seeding and spreading is not known. In the present study, we have inoculated well-characterized sarkosyl-insoluble fractions of sporadic Alzheimer’s disease (sAD) into the brain of adult wild-type mice (Prnp), Prnp (ZH3 strain) mice, and mice over-expressing the secreted form of PrP lacking their GPI anchor (Tg44 strain). Phospho-tau (ptau) seeding and spreading involving neurons and oligodendrocytes were observed three and six months after inoculation. 3Rtau and 4Rtau deposits from the host tau, as revealed by inoculating Mapt mice and by using specific anti-mouse and anti-human tau antibodies suggest modulation of exon 10 splicing of the host mouse Mapt gene elicited by exogenous sAD-tau. However, no tau seeding and spreading differences were observed among Prnp genotypes. Our results show that PrP does not affect tau seeding and spreading in vivo., J.A. del Río and R. Gavín were supported by PRPCDEVTAU PID2021-123714OB-I00, ALTERNed PLEC2022-009401, PDC2022-133268-I00 and ADNano from Plan Complementario de Biotecnología Aplicada a la Salud (C17.I1) funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”, the CERCA Programme, and by the Commission for Universities and Research of the Department of Innovation, Universities, and Enterprise of the Generalitat de Catalunya (SGR2021-00453). Te project leading to these results received funding from “la Caixa” Foundation (ID 100010434) under the agreement LCF/PR/HR19/52160007 to JADR and IF. V. Gil was supported by the María de Maeztu Unit of Excellence (Institute of Neurosciences, University
of Barcelona) MDM-2017-0729. J. Sala-Jarque was supported by the Tatiana Pérez de Guzmán el Bueno Foundation. I. Martínez-Soria was supported by MICINN (FPI Programme, PRE2022-103197) and P. Picón-Pagès was supported by Ciberned., Peer reviewed